Results 151 to 160 of about 8,597,475 (170)

A novel LC-MS/MS approach to the pharmacokinetic study of free and bound aflibercept simultaneously

Analytical and Bioanalytical Chemistry, 2020
Fei Yu, Liu Wanhui, Fangjie Liu
exaly  

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study

Gynecologic Oncology, 2012
Robert L Coleman, R Katherine Alpaugh, Michael W Sill   +2 more
exaly  

Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study

Annals of Oncology, 2016
Stephen P Ackland, Ralf Hofheinz, Gunnar Folprecht   +2 more
exaly  

Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway

Biochemical Pharmacology, 2019
Salvatore Salomone, Giovanni Giurdanella, Claudio Bucolo   +2 more
exaly  

Comparison of Efficacy of Intravitreal Ranibizumab and Aflibercept in Eyes with Myopic Choroidal Neovascularization: 24-Month Follow-Up

Journal of Ocular Pharmacology and Therapeutics, 2020
Nataliya Pasyechnikova, Oleg Zadorozhnyy, Andrii Korol   +2 more
exaly  

A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites

Gynecologic Oncology, 2012
Serafina Mammoliti, Giorgia Mangili, Nicoletta Colombo   +2 more
exaly  

Aflibercept with adjuvant micropulsed yellow laser versus aflibercept monotherapy in diabetic macular edema

Graefe's Archive for Clinical and Experimental Ophthalmology, 2019
Sherein Hagras, Ameera Gamal Abdelhameed   +1 more
exaly  

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer

European Journal of Cancer, 2013
Carlo Barone, Philip Philip, Armando Santoro   +2 more
exaly  

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

European Journal of Cancer, 2014
Josep Tabernero, Paul Ruff, Vladimir Moiseyenko   +2 more
exaly  

Aflibercept—a Decoy VEGF Receptor

Current Oncology Reports, 2014
Jordan Berlin, Kristen K Ciombor
exaly